Solórzano-Vázquez J F, Hernández-Higareda S, Segura-Zavala J M, OsegueraTorres L F, De la Rosa-Hernández S S
Ginecol Obstet Mex. 2016 Aug;84(8):491-7.
Placenta accreta (abnormal insertion of the placenta or part of the myometrium ) endangers the lives of pregnant women. It is a public health problem because it can be complicated by obstetric hemorrhage , the latter being the main cause of maternal death worldwide.
To estimate the blood loss and the use of blood products in patients who underwent cesarean – hysterectomy for placenta accreta.
A descriptive study was conducted in HGO UMAE CMNO IMSS in patients who underwent cesarean – hysterectomy for placenta accreta in a period of 4 years.
106 cases of placenta accreta were studied, 23% had a massive bleeding of > 3000 cc. Packed red blood cells were transfused in 68% of events, fresh frozen plasma in platelet concentrates 29% and 6%. The history of uterine curettage was observed in 64 % and cesarean section 1 or 2 occasions in 76 % of cases.
An early detection of placenta accreta in patients with risk factors to avoid emergency surgery is desired. Being prepared with blood products and appropriate use is a cornerstone in the management of this condition. The average blood loss was determined in cases of accreta in cesarean hysterectomy was 2523 milliliters.
胎盘植入（胎盘或部分肌层异常植入）危及孕妇生命。它是一个公共卫生问题，因为可能并发产科出血，而产科出血是全球孕产妇死亡的主要原因。
评估因胎盘植入而行剖宫产子宫切除术患者的失血量及血制品使用情况。
对墨西哥社会保险局下属的HGO UMAE CMNO医院4年内因胎盘植入而行剖宫产子宫切除术的患者进行描述性研究。
研究了106例胎盘植入病例，23%出现了超过3000毫升的大量出血。68%的情况下输注了浓缩红细胞，29%输注了新鲜冰冻血浆，6%输注了血小板浓缩物。64%的病例有子宫刮宫史，76%的病例有1次或2次剖宫产史。
希望对有危险因素的患者尽早发现胎盘植入，以避免急诊手术。备好血制品并合理使用是处理这种情况的基石。剖宫产子宫切除术中胎盘植入病例的平均失血量为2523毫升。
